Abstract:Antivirulence therapy by cell membrane coated nanoparticles has shown promise against bacterial infections. However, current approaches remain unsatisfactory when facing Escherichia coli (E. coli) infections, since the E. coli secretes multiple bacterial toxins including endotoxins and exotoxins that are challenging to eliminate simultaneously. What is worse, the absorptive scavengers normally rely on random contact of the diffuse toxins, which is not efficient. For the current cell membrane coated platform, the single type of cell membrane cannot fully meet the detoxing requirement facing multiple toxins. To address these problems, a polymyxin B (PMB)-modified, red blood cell (RBC)-mimetic hybrid liposome (P-RL) was developed. The P-RL was fabricated succinctly through fusion of PMB-modified lipids and the RBC membranes. By the strong interaction between PMB and the E. coli membrane, P-RL could attach and anchor to the E. coli; attributed to the fused RBC membrane and modified PMB, the P-RL could then efficiently neutralize both endotoxins and exotoxins from the toxin fountainhead. In vitro and in vivo results demonstrated the P-RL had a significant anchoring effect to E. coli. Moreover, compared with the existing RBC vesicles or PMB-modified liposomes, P-RL exhibited a superior therapeutic effect against RBC hemolysis, macrophage activation, and a mixed-toxin infection in mice. Potently, P-RL could inhibit E. coli O157:H7-induced skin damage, intestinal infection, and mouse death. Overall, the P-RL could potentially improve the detoxing efficiency and markedly expand the detoxification spectrum of current antivirulence systems, which provides different insights into drug-resistant E. coli treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c04800?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c04800</a>.Figures S1–S19, methods and results of PMB lipid synthesis, expression of HlyA, neutralization of α-hemolysin and E. coli O157:H7 toxin, macrophage activation model, therapeutic effect of P-RL in mixed-toxin model, therapeutic effect of P-RL at different infection stages and degrees, therapeutic effect of P-RL on intestinal infection model, biocompatibility of P-RL (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c04800/suppl_file/nn0c04800_si_001.docx">DOCX</a>)This article has not yet been cited by other publications.

Selective reaction of conjugated polymers with basic proteins for broad-spectrum antivirulence therapy

In Situ Capture of Bacterial Toxins for Antivirulence Vaccination

Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A

Cascade-Targeted Nanoplatforms for Synergetic Antibiotic/ROS/NO/Immunotherapy against Intracellular Bacterial Infection

Engineering nanoparticle antitoxins utilizing aromatic interactions

Bacteria - Anchoring Hybrid Liposome Capable of Absorbing Multiple Toxins for Antivirulence Therapy of Escherichia coli Infection

Supplementation of polyclonal antibodies, developed against epitope-string toxin-specific peptide immunogens, to commercial polyvalent antivenom, shows improved neutralization of Indian Big Four and Naja kaouthia snake venoms

Multiantigenic Nanotoxoids for Antivirulence Vaccination against Antibiotic-Resistant Gram-Negative Bacteria.

Broad-spectrum and Powerful Neutralization of Bacterial Toxins by Erythroliposomes with the Help of Macrophage Uptake and Degradation

Plug and play virus-like particles for the generation of anti-toxin antibodies

Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper

The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms

Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E

Development and optimization of a DNA aptamer to delay β-bungarotoxin-induced lethality in a rodent model

Selective Decoating-Induced Activation of Supramolecularly Coated Toxic Nanoparticles for Multiple Applications

Gram‐Negative Bacteria Targeting AIE Photosensitizer for Selective Photodynamic Killing of Vibrio vulnificus

De novo designed proteins neutralize lethal snake venom toxins

Anti-Coronavirus Potential of Polyether Ionophores: The New Application of Veterinary Antibiotics in Livestock

Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins

A multiantigenic antibacterial nanovaccine utilizing hybrid membrane vesicles for combating Pseudomonas aeruginosa infections

Function and Mechanism of Antiviral Wasp Venom Peptide Protopolybia-MP III and Its Derivatives against HSV-1